| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/JVIM.15078 |
| P8608 | Fatcat ID | release_aq7k2mmsjzgjnmx3gjo4brwlia |
| P932 | PMC publication ID | 5980452 |
| P698 | PubMed publication ID | 29575239 |
| P50 | author | Andy E Durham | Q88162823 |
| P2093 | author name string | Andy E Durham | |
| P2860 | cites work | Concentrations of gentamicin in serum and bronchial lavage fluid after once-daily aerosol administration to horses for seven days | Q44900774 |
| Role of coagulase-negative staphylococci in human disease | Q46262568 | ||
| Aminoglycoside-Induced Cochleotoxicity: A Review | Q47134842 | ||
| Microdilution antimicrobial susceptibilities of selected gram-negative veterinary bacterial isolates | Q50157573 | ||
| In-vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in The Netherlands. | Q50161273 | ||
| Disposition of gentamicin administered intravenously to horses with sepsis | Q68091308 | ||
| Gentamicin sulfate in the horse: serum, synovial, peritoneal, and urine concentrations after single dose intramuscular administration | Q70432271 | ||
| Pharmacokinetics of a high dose of gentamicin administered intravenously or intramuscularly to horses | Q77427124 | ||
| Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals | Q83021959 | ||
| Aminoglycoside monitoring: timing of peak levels is critical | Q93625137 | ||
| Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. | Q30328332 | ||
| Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria | Q33976467 | ||
| Therapeutic drug monitoring of antimicrobials | Q35640430 | ||
| Uterine microbiology and antimicrobial susceptibility in isolated bacteria from mares with fertility problems | Q35695689 | ||
| A critical reevaluation of the "therapeutic range" of aminoglycosides | Q36043679 | ||
| Pharmacokinetics and pharmacodynamics of antibacterial agents | Q36911111 | ||
| Plasma Peak and Trough Gentamicin Concentrations in Hospitalized Horses Receiving Intravenously Administered Gentamicin | Q36975688 | ||
| Temporal trends in in vitro antimicrobial susceptibility patterns of bacteria isolated from foals with sepsis: 1979-2010. | Q38117672 | ||
| Antimicrobial resistance in equine faecal Escherichia coli isolates from North West England | Q40487104 | ||
| Once-daily dosing of aminoglycosides: review and recommendations for clinical practice | Q41530531 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Drug disposition and dosage determination of once daily administration of gentamicin sulfate in horses after abdominal surgery | Q44871766 | ||
| P433 | issue | 3 | |
| P921 | main subject | gentamicin | Q422482 |
| P304 | page(s) | 1194-1201 | |
| P577 | publication date | 2018-03-25 | |
| P1433 | published in | Journal of Veterinary Internal Medicine | Q15762439 |
| P1476 | title | An evaluation of serum gentamicin concentrations and bacterial susceptibility to gentamicin in equine practice | |
| P478 | volume | 32 |
| Q92065357 | Antimicrobial susceptibility of bacterial isolates from ambulatory practice and from a referral hospital | cites work | P2860 |
Search more.